An overview on non-T cell pathways in transplant rejection and tolerance

Current Opinion in Organ Transplantation

Volumn 15, Issue 4, 2010, Pages 422-426

  Liu, Wentao ^a   Li, Xian C ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

dendritic cells; innate immunity; natural killer cells; tolerance; transplantation

Indexed keywords

CD11 ANTIGEN; CD11B ANTIGEN; CD28 ANTIGEN; CD56 ANTIGEN; CD94 ANTIGEN; HETERODIMER; INTERLEUKIN 1; INTERLEUKIN 15; INTERLEUKIN 6; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR ALPHA;

ADAPTIVE IMMUNITY; ALLOGRAFT; ALLOIMMUNITY; CELL ACTIVATION; CELL INFILTRATION; CELL SURFACE; CELLULAR IMMUNITY; DENDRITIC CELL; GRAFT REJECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; INFLAMMATORY CELL; INNATE IMMUNITY; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; NONHUMAN; ORGAN TRANSPLANTATION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE; ALLOTRANSPLANTATION; ANIMAL; GRAFT SURVIVAL; IMMUNOLOGY;

ANIMALS; DENDRITIC CELLS; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; MACROPHAGES; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS;

EID: 77955226835     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/MOT.0b013e32833b7903     Document Type: Review

References (48)

1. Auchincloss H Jr, Sultan H. Antigen processing and presentation in transplantation. Curr Opin Immunol 1996; 8:681-687.
2. Hall BM. Cells mediating allograft rejection. Transplantation 1991; 51:1141-1151.
3. Alegre ML, Florquin S, Goldman M. Cellular mechanisms underlying acute graft rejection: time for reassessment. Curr Opin Immunol 2007; 19:563-568.
4. Yu G, Xu X, Vu MD, et al. NK cells promote transplant tolerance by killing donor antigen-presenting cells. J Exp Med 2006; 203:1851-1858.
5. Zhou X, Bailey-Bucktrout S, Jeker LT, Bluestone JA. Plasticity of CD4+Foxp3+ T cells. Curr Opin Immunol 2009; 21:281-285.
6. Kroemer A, Edtinger K, Li XC. The innate NK cells in transplant rejection and tolerance induction. Curr Opin Organ Transplant 2008; 13:339-343.
7. Vivier E, Tomasello E, Baratin M, et al. Functions of natural killer cells. Nat Immunol 2008; 9:503-510.
8. Lanier LL. NK cell recognition. Annu Rev Immunol 2005; 23:225-274.
9. Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 2005; 436:709-713.
10. Walzer T, Jaeger S, Chaix J, Vivier E. Natural killer cells: from CD3-NKp46+ to postgenomics meta-analyses. Curr Opin Immunol 2007; 19:365-372.
11. Lanier LL. NK cell receptors. Annu Rev Immunol 1998; 16:359-393.
12. Flodström-Tullberg M, Bryceson YT, Shi FD, et al. Natural killer cells in human autoimmunity. Curr Opin Immunol 2009; 21:634-640.
13. Ruggeri L, Mancusi A, Capanni M, et al. Exploitation of alloreactive NK cells in adoptive immunotherapy of cancer. Curr Opin Immunol 2005; 17:211-217.
14. Lin Y, Vandeputte M, Waer M. Natural killer cell- and macrophage-mediated rejection of concordant xenografts in the absence of T and B cell responses. J Immunol 1997; 158:5658-5667.
15. Maier S, Tertilt C, Chambron N, et al. Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/- mice. Nat Med 2001; 7:557-562.
16. McNerney ME, Lee KM, Zhou P, et al. Role of natural killer cell subsets in cardiac allograft rejection. Am J Transplant 2006; 6:505-513.
17. Uehara S, Chase CM, Kitchens WH, et al. NK cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. J Immunol 2005; 175:3424-3430.
18. Kroemer A, Xiao X, Degauque N, et al. The innate NK cells, allograft rejection, and a key role for IL-15. J Immunol 2008; 180:7818-7826.
19. Fehniger TA, Caligiuri MA. Interleukin-15: biology and relevance to human disease. Blood 2001; 97:14-32.
20. Cooper MA, Elliott JM, Keyel PA, et al. Cytokine-induced memory-like natural killer cells. Proc Nat Acad Sci 2009; 106:1915-1919.
21. Sun JC, Beilke JN, Lanier LL. Adaptive immune features of natural killer cells. Nature 2009; 457:557-561.
22. Beilke JN, Kuhl NR, Kaer LV,Gill RG. NK cells promote islet allograft tolerance via a perforin-dependent mechanism. Nat Med 2005; 11:1059-1065.
23. Garrod KR, Liu F-C, Forrest LE, et al. NK cell patrolling and elimination of donor-derived dendritic cells favor indirect alloreactivity. J Immunol 2010; 184:2329-2336.
24. Rulifson IC, Szot GL, Palmer E, Bluestone JA. Inability to induce tolerance through direct antigen presentation. Am J Transplant 2002; 2:510-519.
25. Laffont S, Seillet C, Ortaldo J, et al. Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood 2008; 112:661-671.
26. Li XC, Strom TB, Turka LA, Wells AD. T cell death and transplantation tolerance. Immunity 2001; 14:407-416.
27. Degli-Esposti MA, Smyth MJ. Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 2005; 5:112-124.
28. Rabinovich BA, Shannon J, Su RC, Miller RG. Stress renders T cell blasts sensitive to killing by activated syngeneic NK cells. J Immunol 2000; 165:2390-2397.
29. Roy S, Barnes PF, Garg A, et al. NK cells lyse T regulatory cells that expand in response to an intracellular pathogen. J Immunol 2008; 180:1729-1736.
30. Deniz G, Erten G, Kucuksezer UC, et al. Regulatory NK cells suppress antigen-specific T cell responses. J Immunol 2008; 180:850-857.
31. Vosshenrich CAJ, Lesjean-Pottier S, Hasan M, et al. CD11cloB220+ interferon- producing killer dendritic cells are activated natural killer cells. J Exp Med 2007; 204:2569-2578.
32. Steinman RM, Nussenzweig MC. Dendritic cells: features and functions. Immunol Rev 1980; 53:127-147.
33. Ohnmacht C, Pullner A, King SBS, et al. Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity. J Exp Med 2009; 206:549-559.
34. Morelli AE, Thomson AW. Tolerogenic dendritic cells and the quest for transplant tolerance. Nat Rev Immunol 2007; 7:610-621.
35. Shortman K, Liu YJ. Mouse and human dendritic cell subtypes. Nat Rev Immunol 2002; 2:151-161.
36. Ochando JC, Homma C, Yang Y, et al. Alloantigen-presenting plasmacytoid dendritic cells mediate tolerance to vascularized grafts. Nat Immunol 2006; 7:652-662.
37. Ito T, Amakawa R, Inaba M, et al. Plasmacytoid dendritic cells regulate Th cell responses through OX40 ligand and type I IFNs. J Immunol 2004; 172: 4253-4259.
38. Shortman K, Naik SH. Steady state and inflammatory dendritic cell development. Nat Rev Immunol 2007; 7:19-30.
39. Turnquist HR, Raimondi G, Zahorchak AF, et al. Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance. J Immunol 2007; 178:7018-7031.
40. Turnquist HR, Thomson AW. Taming the lions: manipulating dendritic cells for use as negative cellular vaccines in organ transplantation. Curr Opin Organ Transplant 2008; 13:350-357.
41. Langrehr JM, White DA, Hoffman RA, Simmons RL. Macrophages produce nitric oxide at allograft sites. Ann Surg 1993; 218:159-166.
42. Magil AB. Monocytes/macrophages in renal allograft rejection. Transplant Rev 2009; 23:199-208.
43. Kimura A, Naka T, Kishimoto T. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci 2007; 104:12099-12104.
44. Burlingham WJ, Love RB, Jankowska-Gan E, et al. IL-17 dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants. J Clin Invest 2007; 117:3498-3506.
45. Dong C. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat Rev Immunol 2008; 8:337-348.
46. Kitchens WH, Chase CM, Uehara S, et al. Macrophage depletion suppresses cardiac allograft vasculopathy in mice. Am J Transplant 2007; 7:2675-2682.
47. Knechtle S, Pirsch JD, Fechner JH, et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant 2003; 3:643-645.
48. Brem-Exner BG, Sattler C, Hutchinson JA, et al. Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol 2008; 180:335-349.